Eric Galia

Diphenylazetidinone with improved physiological properties, process for its preparation, medicaments comprising this compound, and its use

Novel diphenyl azetidinone with improved physiological characteristics, corresponding production method, medicaments containing said compound and use of the latter

Neues diphenylazetidinon mit verbesserten physiologischen eigenschaften, verfahren zu dessen herstellung, diese verbindungen enthaltende arzneimittel und dessen verwendung

NOVEL DIPHENYLAZETIDINONE, PROCESS FOR ITS PREPARATION, MEDICAMENTS COMPRISING THIS COMPOUND AND THEIR USE

NUEVA DIFENILAZETIDINONA CON CARACTERISTICAS FISIOLOGICAS MEJORADAS CORRESPONDIENTE METODO DE PRODUCCION , MEDICAMENTOS QUE LO CONTIENEN Y USO DE LOS MISMOS

11-((4R,6R)-4,5,6-trihydroxy-3-(R)-hydroxy-2-(S)-hydroxy-hexylcarbamoyl)-undecanoic acid

Neues diphenylazetidinon mit verbesserten physiologischen eigenschaften, verfahren zu dessen herstellung, diese verbindung enthaltende arzneimittel und dessen verwendung New diphenylazetidinone having improved physiological properties, process for its manufacture, containing this compound drug and its use

11-((4R,6R)-4,5,6-Trihydroxy-3-(R)-hydroxy-2-(S)-hydroxy-hexylcarbamoyl)-Undekansäure 11 - ((4R, 6R) -4,5,6-trihydroxy-3- (R) -hydroxy-2- (S) -hydroxy-hexylcarbamoyl) -Undekansäure

Nouveau diphenylazetidinone a proprietes physiologiques ameliorees, procedes de production associe, medicaments contenant les composes et leurs utilisations

Acid 11 - ((4R, 6R) -4,5,6-trihydroxy-3- (R) -hydroxy-2- (s) -hydroxy-hexylcarbamoyl) -undecanoico.